title: Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma.
abstract: EphA3 is a component of the Eph/ephrin tyrosine kinase system, which participates in vasculature development. This receptor/ligand system is associated with various signaling pathways related to cell growth and viability, cytoskeletal organization, cell migration, and anti-apoptosis. Accumulated evidence suggests that aberrant regulation of EphA3 and its genetic alterations are implicated in the development and progression of various cancers. However, despite a high incidence of EphA3 over-expression, no such investigation has been performed in hepatocellular carcinoma. Thus, we investigated genetic alterations of the EphA3 gene in 73 cases of hepatocellular carcinoma by single-strand conformational polymorphism and sequencing. One novel D219V missense mutation was found in the extracellular domain of EphA3, and two genetic alterations in the intracellular sterile-alpha-motif (SAM) domain of EphA3 appeared to be polymorphisms. Although the functional assessments of this mutant are incomplete, it is believed that this novel EphA3 mutation may contribute to the development of hepatocellular carcinoma.
authors.affiliation: Department of Pathology, Microdissection Genomics Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.
authors.forename: H J
authors.initials: HJ
authors.lastname: Bae
authors.forename: J H
authors.initials: JH
authors.lastname: Song
authors.forename: J H
authors.initials: JH
authors.lastname: Noh
authors.forename: J K
authors.initials: JK
authors.lastname: Kim
authors.forename: K H
authors.initials: KH
authors.lastname: Jung
authors.forename: J W
authors.initials: JW
authors.lastname: Eun
authors.forename: H J
authors.initials: HJ
authors.lastname: Xie
authors.forename: J C
authors.initials: JC
authors.lastname: Ryu
authors.forename: Y M
authors.initials: YM
authors.lastname: Ahn
authors.forename: S Y
authors.initials: SY
authors.lastname: Kim
authors.forename: S H
authors.initials: SH
authors.lastname: Lee
authors.forename: N J
authors.initials: NJ
authors.lastname: Yoo
authors.forename: J Y
authors.initials: JY
authors.lastname: Lee
authors.forename: W S
authors.initials: WS
authors.lastname: Park
authors.forename: S W
authors.initials: SW
authors.lastname: Nam
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense / Q000235:genetics*; D009367:Neoplasm Staging; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D011379:Prognosis; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D036121:Receptor, EphA3
chemical_list: C491718:EPHA3 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D036121:Receptor, EphA3